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ABSTRACT: A two-photon fluorescent probe based on a
ruthenium(II) vinyl complex is capable of selectively
detecting carbon monoxide in cells and ex vivo using mice
with a subcutaneous air pouch as a model for
inflammation. This probe combines highly selective and
sensitive ex vivo detection of endogenous CO in a realistic
model with facile, inexpensive synthesis, and displays many
advantages over the widely used palladium-based systems.
The toxic effect of carbon monoxide in humans is due to thehigh affinity of CO for iron, reducing the oxygen transport
capacity of hemoglobin, and the fact that the gas is broadly
inhibitory for heme proteins and nonheme iron enzymes,
including hydrogenase1 and nitrogenase.2 Paradoxically, more
than half a century ago it was found that CO is routinely formed
endogenously in humans in small quantities, and that under
certain pathophysiological conditions, CO production in-
creases.3
In the body, CO serves many functions, including anti-
inflammatory, antiproliferative, antiapoptotic and anticoagula-
tive roles. It is also an intrinsic metal ligand in enzymes and acts
as a gaseous signaling molecule in mammals.4 Hemoglobin is
required as a substrate for the production of CO in vivo and
heme oxygenases (HO-1 and HO-2) are implicated in the
generation of this gas in mammals. There is also evidence that an
increased generation of HO-derived CO plays a critical role in
the resolution of inflammatory processes and alleviation of
cardiovascular disorders.5
CO-releasing molecules (CORMs) are capable of liberating
controlled amounts of CO in biological systems and this has led
to their investigation for the prevention of vascular dysfunction,
inflammation, tissue ischemia and organ rejection.6
One of the major obstacles limiting progress in understanding
the biological role of CO and its therapeutic application is the
lack of real-time methods to selectively track CO in biological
systems. Recently, fluorescence sensing and imaging with
emissive probes has emerged as one of the most powerful
techniques to detect biologically important molecules.7 Until
very recently, the most significant breakthroughs came from the
groups of He8 and Chang,9 which reported two different types
of fluorescent probes for the imaging of CO in living cells.
Following those pioneering contributions, many probes (almost
all based on palladium) have been developed and applied for cell
imaging of CO.10 However, these probes are either complicated,
difficult to synthesize, require excitation by photodamaging UV
light, have delayed fluorescence response times (commonly
between 40 and 60 min in the palladium-based systems), use
cytotoxic nonligated heavy metal salts (as carbonylation
catalysts or Tsuji-Trost reaction mediators) or the addition of
high concentrations of organic cosolvents.10 For these reasons,
the development of a simple fluorogenic probe with improved
features capable of detecting CO in living systems is therefore a
particularly timely area of research.
Two-photon fluorescence microscopy offers many advantages
over conventional confocal microscopy. It allows the study of
biological samples in three dimensions with submicrometer
resolution, while the near-IR light used reduces specimen
photodamage and provides greater penetration, allowing higher
contrast imaging. This has led to substantial interest in the
design of new two-photon fluorophores for biological sensing.11
In view of the aspects mentioned above, we report herein a
novel molecular probe for the two-photon fluorogenic detection
of CO in biological environments using the IDA paradigm
pioneered by Anslyn.12 The probe (complex 6 in Scheme 1)
takes inspiration from previously described ruthenium(II)
complexes with fluorogenic vinyl substituents, which display
exceptional results for the detection of CO in air.13 However, a
crucial difference in compound 6 is the use of a new
fluorophore, 5-(3-thienyl)-2,1,3-benzothiadiazole (TBTD), as
a signaling unit, which is coordinated directly to the metal
center. A major drawback of these previously reported
ruthenium(II) vinyl complexes is their very low water solubility
which prevents their direct application for CO sensing in
aqueous systems. The use of water-soluble phosphines was
found to lead to undesired effects on the sensing behavior so an
alternative strategy was employed to introduce hydrophilic
groups to the vinyl substituent. Probe 6 was successfully
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synthesized using a terminal alkyne with an oligoethylene glycol
moiety (HCCL in Scheme 1). The design of 6 thus
incorporates many characteristics needed for the sensing of
carbon monoxide in cells. Its solubility in water, the immediate
fluorogenic response, the outstanding emission enhancement
and the exceptional sensitivity and selectivity make this complex
a unique candidate for this application (vide inf ra).
The new two-photon fluorophore, TBTD, was prepared using
a Suzuki coupling and was spectroscopically and structurally
characterized (Supporting Information). The synthesis of probe
6 is shown in Scheme 1b, commencing from commercially
available 3. Perhaps due to the oligoethylene glycol chain,
compound 6 failed to yield crystals suitable for a structural
determination. In order to unequivocally determine the bonding
mode and orientation of the coordinated TBTD ligand, the 9-
phenanthrenyl analogue [Ru(CHCHPhen-9)Cl(CO)-
(TBTD)(PPh3)2] (7) was prepared (Supporting Information).
X-ray diffraction of single crystals of 7 and its CO adduct (7·
CO)13a allowed structural information to be obtained (Figure
1).
The fluorogenic behavior of probe 6 in aqueous environments
was first investigated in the absence and in the presence of CO.
Analysis of a PBS (pH 7.4)−acetone 99.9:0.1 v/v solution of
probe 6 (1.0 × 10−5 mol L−1) revealed a very weak emission
band centered at ca. 500 nm (upon excitation at 355 nm). The
weak nature of this emission was ascribed to quenching of the
TBTD fluorescence by the Ru(II) center (heavy atom effect).
Passing increasing quantities of CO gas into the aqueous
solution of probe 6 induced a progressive enhancement of the
emission at 500 nm (Figure 2). The observed emission
enhancement was attributed to the dissociation of TBTD
from the complex upon CO binding and this displacement was
confirmed experimentally (Figure S2-20). The replacement of
the labile TBTD ligand by CO was found to disrupt the
quenching effect of the Ru(II) center and accounted for the
emission enhancement observed (see Scheme 1b). The product
formed, [Ru(CHCHL)Cl(CO)2(PPh3)2] (6·CO), was also
fully characterized (Supporting Information).
The stability of complex 6 in aqueous solution was assessed
by recording fluorescence spectra every 5 min in the presence
and absence of CO over a 1 h period. As no emission
enhancement was observed in the absence of CO, it can be
concluded that the fluorescence response results from the
presence of this gas in solution and not due to spontaneous
release of the TBTD ligand (e.g., through displacement by
water). Although the cellular matrix is difficult to reproduce, 100
μM concentrations of reactive nitrogen and oxygen species, such
as tryptophan, cysteine, BSA, imidazole, NOx, hydroxide,
peroxide, were also added to aqueous solutions of probe 6,
while the emission intensity was monitored. No significant
increase in the TBTD emission was observed on addition of
these compounds, confirming the selectivity of the probe toward
CO (Figure S4-2). Further tests confirmed the solution and
photostability of probe 6 (Figures S4-4, S4-5 in Supporting
Information).
Scheme 1. (a) Synthesis of HCCL; (b) Preparation of 6
and Reaction of 6 with CO; (c) Crystal Structure of TBTD
(Supporting Information)
Figure 1. Crystal structures of 7 (above) and 7·CO (below).
Figure 2. Turn-on fluorescence response (excitation at 355 nm) of a
1.0 × 10−5 mol L−1 of PBS (pH 7.4)−acetone 99.9:0.1 v/v solution of
probe 6 upon addition of increasing quantities of CO (0−100 ppm and
0−100 ppb).
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These experiments successfully demonstrated the potential of
probe 6 for sensing CO in cells as the probe is (i) sufficiently
soluble in water, (ii) selective for CO, producing a remarkable
fluorescence enhancement, (iii) emissive at higher wavelengths
than the range typical of protein emissions (250−400 nm) and
(iv) two-photon active (vide inf ra). These design properties are
vitally important for single-molecule imaging in cells.
Following the encouraging results described above, the
imaging of CO in living cells was investigated using probe 6.
The mouse macrophage RAW 264.7 cell line was selected as it
can induce HO-1 and generate CO under different physiological
conditions.14 Viability assays (MTT) using RAW 264.7 cells
demonstrated the nontoxicity of probe 6, also in the presence of
CORM-3 and hemin (Figure S5-1). Following this favorable
toxicity assessment, the ability of probe 6 to visualize changes in
CO levels in cells was tested. RAW 264.7 cells were incubated
with probe 6 (10 μM) for 30 min, leading to no discernible
emission (Figure 3A). However, when the cells were
preincubated with the CO source, CORM-3, and then treated
with probe 6 (10 μM), a dose-dependent intracellular two-
photon fluorescence response was clearly observed (Figure
3B,C).
Carbon monoxide is naturally generated by the action of HO
on heme produced by the rupture of hemoglobin. Also, heme
administration is known to increase HO-1 expression and
activity leading to subsequent CO generation.15 Accordingly,
RAW 264.7 cells were treated with hemin chloride in order to
enhance intracellular CO levels, and so to further examine the
ability of probe 6 to detect CO. Again, MTT viability assays
were carried out to assess the toxicity of the hemin/probe 6
treatment in RAW 264.7 cells. Cells were treated with hemin
(100 μM) for 0.5, 3, and 6 h and then probe 6 (10 μM) was
added 30 min before imaging. Two controls were used: (i) cells
without any treatment and (ii) cells treated only with probe 6
(10 μM) for 30 min. The viability experiments showed no
toxicity for 6 in the presence of hemin (Figure S5-1).
RAW 264.7 cells were incubated with hemin (100 μM) for 3
h, then with probe 6 (10 μM) for 5, 10, 20, and 30 min prior to
imaging. The two-photon excitation microscopy images
obtained are shown in Figure S5-2. The RAW 264.7 cells
treated with hemin and probe 6 showed a marked green
emission that was again ascribed to the TBTD fluorophore
released from probe 6 upon reaction with the CO generated.
Moreover, a dose dependent response was observed when cells
were treated with different hemin concentrations during the
same time period (Figure 4). This showed a 10-fold enhance-
ment when 100 μM hemin was used.
The response time for CO detection in the above experiments
was rapid with maximum emission after only 10 min of probe
incubation (Figure S5-2). This compares favorably with the 60
min response time of the ground-breaking molecular probe
reported by Chang.9 The first two-photon system for CO
detection in cells was the elegant cyclopalladated carbazole−
coumarin scaffold reported by Lin et al.10a However, its
drawbacks included the 7-step synthetic route from commercial
reagents, the high CORM-2 concentration used (200 μM) and
the long response time (40 min). Even improved systems10j
require 60 min for the best results and the nature and impact of
the undefined Pd species released is unknown. Following
confirmation that probe 6 successfully detects small changes in
intracellular CO, the potential and versatility of probe 6 for ex
vivo CO detection was explored using a subcutaneous air pouch
inflammation mouse model.
The cellular stress protein HO-1 serves a vital metabolic
function for limiting the rate of degradation of heme to generate
carbon monoxide, iron and biliverdin-IXα (which converts to
bilirubin-IXα).
5,6 Lipopolysaccharides (LPS) from many bacte-
rial species initiate acute inflammatory responses in mammals
that are typical of the host reaction to tissue injury or infection.
In this scenario, LPS administration into a mouse air pouch
induces an inflammatory reaction characterized by plasmatic
exudation and migration of leukocytes to the cavity.16 It was
anticipated that the LPS would induce HO-1 protein expression
in leukocytes migrating to the air pouch exudates, causing them
to exhibit higher levels of CO than would be expected in the
absence of LPS. Air pouches were produced in female Swiss
mice by subcutaneous injections of 10 mL sterile air into the
back. After 3 days, 5 mL of sterile air were injected into the same
cavity. Six days after the formation of air pouches, inflammation
was induced by injection of 1 mL of LPS (1 μg/mL) in saline. A
control group was only injected with 1 mL of saline. After 18 h, 3
mL of probe 6 (50 μM) was injected into the air pouch. After 30
min, mice were culled and the exudates in the pouch were
collected and visualized using two-photon microscopy. As
shown in Figure 5, cells from mice treated with LPS and probe 6
showed a remarkable increase in fluorescence (Figure 5D)
compared to cells from mice treated with only saline and probe
6 (Figure 5C). As expected, a very low level of fluorescence was
observed in cells from mice treated with LPS without probe 6
(Figure 5B) or only treated with saline (Figure 5A). These
Figure 3. Two-photon excitation microscopy images of RAW 264.7
cells treated for 30 min with (A) 0 μM, (B) 10 μM, and (C) 50 μM of
CORM-3 followed by 10 μM of probe 6 in PBS (pH 7.4)−acetone
99.9:0.1 v/v. Images acquired upon excitation at 715 nm.
Figure 4. (A) Two-photon excitation microscopy images of RAW
264.7 cells treated with 0, 1, 10, or 100 μM of hemin for 3 h before
incubation with probe 6 (10 μM) for 10 min. (B) Ratio of mean
fluorescence intensity of cells plus control cells (no hemin) using
ImageJ software. Data are expressed as mean ± SEM of at least three
independent experiments. Excitation at 715 nm.
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results clearly indicate that probe 6 is able to fluorogenically
detect CO ex vivo in a model of inflammation.
In summary, we have described the design of a Ru(II) vinyl
complex capable of selectively detecting CO through a
remarkable OFF−ON emission enhancement in PBS (pH
7.4)−acetone 99.9:0.1 v/v. Probe 6 is selective for CO even in
the presence of RNS and ROS, which all induced no response.
Probe 6 proved to be nontoxic to cells and can be used in low
doses for the in vitro two-photon fluorescence imaging of CO in
RAW 264.7 cells in the presence of CORM-3 or hemin. Even
more significantly, the probe was successfully used for the ex vivo
two-photon fluorescence detection of CO in cells collected from
the exudates of an air pouch inflammation mouse model. The
combination of selectivity, sensitivity and inexpensive, straight-
forward synthesis make the system described here a very
attractive and efficient probe for the facile fluorogenic detection
of this gas in realistic biological environments.
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Figure 5. Two-photon excitation microscopy images of cells from mice
exudates after 18 h of saline or LPS treatment and 30 min with or
without probe 6 in the air pouch. (A) Mice treated with saline, (B) mice
treated with LPS, (C) mice treated with saline and 50 μM of probe 6,
(D) mice treated with LPS and 50 μM of probe 6. Images were
acquired upon excitation at 715 nm using a multiphoton microscope.
See Figure S5-3 for larger images.
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